NLCCX
Price
$27.21
Change
-$1.09 (-3.85%)
Updated
Apr 10 closing price
Net Assets
699.46M
RGAFX
Price
$66.13
Change
-$2.72 (-3.95%)
Updated
Apr 10 closing price
Net Assets
271.59B
Ad is loading...

NLCCX vs RGAFX

Header iconNLCCX vs RGAFX Comparison
Open Charts NLCCX vs RGAFXBanner chart's image
Voya Large-Cap Growth C
Price$27.21
Change-$1.09 (-3.85%)
VolumeN/A
Net Assets699.46M
American Funds Growth Fund of Amer R5
Price$66.13
Change-$2.72 (-3.95%)
VolumeN/A
Net Assets271.59B
NLCCX vs RGAFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
NLCCX vs. RGAFX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NLCCX is a Buy and RGAFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAFX has more cash in the bank: 272B vs. NLCCX (699M). RGAFX pays higher dividends than NLCCX: RGAFX (0.66) vs NLCCX (0.00). NLCCX was incepted earlier than RGAFX: NLCCX (28 years) vs RGAFX (23 years). NLCCX (1.59) is less costly to investors than RGAFX (0.34). NLCCX is a more actively managed with annual turnover of: 51.00 vs. RGAFX (25.00). RGAFX has a lower initial minimum investment than NLCCX: RGAFX (250) vs NLCCX (1000). RGAFX annual gain was more profitable for investors over the last year : -1.74 vs. NLCCX (-3.48). RGAFX return over 5 years is better than : 52.56 vs. NLCCX (-12.74).
NLCCXRGAFXNLCCX / RGAFX
Total Expense Ratio1.590.34468%
Annual Report Gross Expense Ratio1.590.34468%
Fund Existence28 years23 years-
Gain YTD-11.920-7.485159%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets699M272B0%
Annual Yield % from dividends0.000.66-
Returns for 1 year-3.48-1.74200%
Returns for 3 years-12.009.85-122%
Returns for 5 years-12.7452.56-24%
Returns for 10 years-3.8156.31-7%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIMD0.520.02
+3.63%
Ainos
IKT1.86-0.03
-1.59%
Inhibikase Therapeutics
TRIN13.81-0.36
-2.54%
Trinity Capital
JBL132.04-5.34
-3.89%
Jabil
USAC22.94-1.19
-4.93%
USA Compression Partners LP